Entering text into the input field will update the search result below

Silence Therapeutics: Breaking The Silence On An Under-The-Radar Mid-Stage SiRNA Platform

Mar. 13, 2023 11:58 PM ETSilence Therapeutics plc (SLN)IONS, ALNY, AZN, MNK, HNSPF1 Comment
BiotechValley Insights profile picture
BiotechValley Insights


  • Silence Therapeutics is an underfollowed British siRNA company focusing on cardiovascular and autoimmune diseases.
  • Silence Therapeutics is a de-risked investment opportunity with significant potential upside, supported by its robust pipeline, strategic collaborations, and favorable financial position.
  • We expect multiple clinical catalysts during YE 2023, and the company has 1-2 years of cash runway.
  • We initiate with a speculative buy rating.
DNA strands

Evgenii Kovalev


Silence Therapeutics (NASDAQ:SLN) is a UK-based biotechnology company specializing in RNA interference [RNAi] technology. The company is focused on developing and commercializing a pipeline of therapies using its proprietary platform technology to target and silence disease-causing genes. Silence Therapeutics has a

This article was written by

BiotechValley Insights profile picture
We publish unbiased long/short trade ideas. Please follow our Twitter page: https://twitter.com/biotechvalley_i

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Biotechvalley Insights (BTVI) is not a registered investment advisor, and the articles are not intended for retail investors. The content is for informational purposes only, and readers should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing in BTVI's articles or comments constitutes a solicitation, recommendation, endorsement, or offer by Biotechvalley Insights or any third-party service provider to buy or sell any securities or other financial instruments in any jurisdiction where such solicitation or offer would be unlawful under the securities laws of that jurisdiction. The research and reports published by BTVI reflect and express the opinion of the applicable BTVI entity as of the time of the report only. Reports are based on generally-available information, field research, inferences, and deductions through the applicable due diligence and analytical process. BTVI may use resources from brokerage reports, corporate IR, and KOL/expert interviews that may have a conflict of interest with the company/assets that BTVI covers. To the best of BTVI's ability and belief, all information contained herein is accurate and reliable, is not material non-public information, and has been obtained from public sources that BTVI entity believes to be accurate and reliable. However, this information is presented "as is" without warranty of any kind, whether express or implied. BTVI makes no representation, express or implied, as to the accuracy, timeliness, or completeness of any information, and the results obtained from its use. Further, any analysis/comment contains a very large measure of analysis and opinion. All expressions of opinion are subject to change without notice, and BTVI does not undertake to update or supplement any reports or any of the information, analysis, and opinion contained in them.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.